Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.4K
Overview
44.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ambient AI scribe in pediatric outpatient visits: documentation burden, quality, and scale-up limits.

Medicina clinica·2026
Same author

Large-language-models for pediatric diagnosis: Performance evaluation using real-world clinical notes from common and rare cases.

Pediatric investigation·2026
Same author

Long-Term Functional Outcomes After Pediatric Intensive Care Unit Admission for Bronchiolitis: A 12-Month Cohort Study.

Children (Basel, Switzerland)·2026
Same author

Clinical and immunovirological status in children, adolescents and young adults with early-life-acquired HIV: a Spanish multi-cohort analysis since 2020.

The Journal of antimicrobial chemotherapy·2026
Same author

Oral microbiota composition in children and adults during Spanish COVID-19 lockdown: impact of home self-confinement and SARS-CoV-2 infection.

Journal of oral microbiology·2026
Same author

The Impact of Nirsevimab on the Transport of Critically Ill Children.

Children (Basel, Switzerland)·2026

相关实验视频

Updated: Jun 23, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.8K

在预防严重支气管炎方面,nirsevimab免疫的实际有效性:一个测试负的病例对照研究.

Marta Agüera1, Aleix Soler-Garcia1,2,3, Carme Alejandre4

  • 1Pediatrics Department, Hospital Sant Joan de Déu, Barcelona, Spain.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
|June 20, 2024
PubMed
概括

尼尔西维玛可显著减少婴儿因呼吸道同胞病毒 (RSV) 下呼吸道感染而住院的病例. 这种现实世界的证据支持nirsevimab.

关键词:
支气管炎是一种支气管炎.有效性 有效性.免疫接种 免疫接种 免疫接种没有自己的生活.儿科 儿科 儿科 儿科严重程度的严重程度.

更多相关视频

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.6K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

35.9K

相关实验视频

Last Updated: Jun 23, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.8K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.6K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

35.9K

科学领域:

  • 儿童传染病 儿童传染病
  • 免疫学 免疫学 免疫学
  • 公共卫生 公共卫生

背景情况:

  • 呼吸道共囊病毒 (RSV) 支气管炎是婴儿住院的主要原因之一.
  • 针对RSV的抗体Nirsevimab在临床试验中显示出有前途.
  • 加泰罗尼亚和安道拉在2023-2024年为婴儿实施了nirsevimab免疫战略.

研究的目的:

  • 评估nirsevimab在预防RSV支气管炎住院治疗中的实际有效性.
  • 评估nirsevimab对婴儿严重RSV疾病的影响.
  • 为了比较免疫和非免疫婴儿之间的结果.

主要方法:

  • 在三家医院进行了一项检测阴性病例控制研究.
  • 包括12个月以下的婴儿,他们患有支气管炎并接受了RSV检测.
  • 多变量模型估计了针对RSV住院和严重疾病的有效性.

主要成果:

  • 尼尔西维马布在RSV感染下呼吸道感染住院治疗方面表现出81.0%的有效性.
  • 预防严重疾病 (NIV/CMV) 的有效率为85.6%.
  • 接种疫苗的婴儿的RSV检测率明显较低 (37%vs75%).

结论:

  • 尼尔西维玛 (Nirsevimab) 提供了对RSV住院和婴儿严重疾病的真实保护.
  • 免疫计划在现实环境中显示出高效率.
  • 在免疫婴儿中没有观察到病毒共感染或临床严重性的风险增加.